BioPatch wins the seventh edition of Innomakers4Health, held this past weekend in Madrid, organized by Wayra, Telefónica’s corporate venture capital, Pfizer, and the Pfizer Foundation. This program brings together innovation, technology, and healthcare to address the challenges of the health sector, aiming to design innovative solutions and create prototypes that improve people’s quality of life.
In the ‘Early Innovators’ category, BioPatch was the winner for developing a patch to detect breast cancer through non-invasive, low-cost measurement of the electrical conductivity of cancerous cells. The ‘Startups’ category remained unawarded.
This edition saw the participation of more than 100 entrepreneurs from diverse backgrounds, divided into 21 teams. The resulting projects offered disruptive proposals to accelerate the adoption of biomarkers through technological solutions that make them more accessible, understandable, and useful for clinical decision-making.
Irene Gómez Luque, CEO of Wayra, stated: “At Wayra, we are delighted to see the great local talent and the interest generated by this call to innovate in such a key sector for our society as healthcare. Thanks to Pfizer and the Pfizer Foundation for allowing us to once again be part of Innomakers4Health, where we bring all our expertise in the entrepreneurial ecosystem to connect them with the Spanish healthcare system.”
Sergio Rodríguez, President of the Pfizer Foundation, added: “Collaborative innovation is key to transforming the future of healthcare. Innomakers4Health embodies that spirit, a space where creativity, technology, and social commitment come together to address the major healthcare challenges of our time.” He also emphasized that the Pfizer Foundation launches programs like this “to promote healthcare entrepreneurship, supporting entrepreneurs by providing access to clinical knowledge and collaboration networks in the sector that enhance their projects.”
BioPatch has received a cash prize of €3,000. Additionally, it will have the opportunity to accelerate its project at the InnomakersLAB, Pfizer’s hub in collaboration with Wayra, which will also provide access to a six-month mentorship program and a workspace at their Madrid offices. This experience allows entrepreneurs to continue developing their proposals with the guidance of experts in open innovation.
About Wayra
Wayra is Telefónica’s Corporate Venture Capital. It invests in technology startups with the potential to generate innovation within the group and offers open innovation services to third parties. With a presence in Europe and Latin America, Wayra has invested over €245 million in more than 1,100 startups and currently has an active portfolio of over 530, of which more than 200 collaborate with Telefónica. It also drives open initiatives through its Alaian and Open Future platforms. More information is available at www.wayra.es
About the Pfizer Foundation
For 25 years, the Pfizer Foundation has been committed to promoting science, technology, and innovation and bringing them closer to society. Each year, it renews its strategic focus on scientific, technological, and social innovation by building bridges between research activities and society, aiming to translate scientific advances into practical applications that benefit people. More information: www.fundacionpfizer.org
Pfizer: Innovations that change patients’ lives
Pfizer, as a biomedical company dedicated to improving people’s health, develops innovative therapies and vaccines to cure, prevent, or alleviate diseases. With a history of over 175 years, Pfizer remains committed to society and invests in R&D to address today’s and tomorrow’s medical needs. The advancement of science and technology, as well as its medical application, requires collaboration with all stakeholders to maximize the medicine portfolio and ensure pharmaceutical innovation reaches everyone who needs it—quickly, affordably, reliably, and transparently—according to the highest quality and safety standards. More information: www.pfizer.es
cloud technology axon
Xcalibur Smart Mapping, recognised as the global leader in airborne...
